Nuvation Bio (NUVB) Other financing activities: 2020-2025

Historic Other financing activities for Nuvation Bio (NUVB) over the last 1 years, with Jun 2025 value amounting to $166,000.

  • Nuvation Bio's Other financing activities fell 97.37% to $166,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $11.5 million, marking a year-over-year increase of 75.88%. This contributed to the annual value of $17.2 million for FY2024, which is 572200.00% up from last year.
  • According to the latest figures from Q2 2025, Nuvation Bio's Other financing activities is $166,000, which was down 68.91% from $534,000 recorded in Q1 2025.
  • Nuvation Bio's 5-year Other financing activities high stood at $7.6 million for Q4 2024, and its period low was -$3,000 during Q4 2023.
  • Over the past 3 years, Nuvation Bio's median Other financing activities value was $1.9 million (recorded in 2024), while the average stood at $3.0 million.
  • In the last 5 years, Nuvation Bio's Other financing activities spiked by 254,533.33% in 2024 and then plummeted by 97.37% in 2025.
  • Nuvation Bio's Other financing activities (Quarterly) stood at -$3,000 in 2023, then spiked by 254,533.33% to $7.6 million in 2024, then tumbled by 97.37% to $166,000 in 2025.
  • Its Other financing activities was $166,000 in Q2 2025, compared to $534,000 in Q1 2025 and $7.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other financing (Qtr)
1 Summit Therapeutics Inc. 1,387.71B 1,387.50B - -
2 BeOne Medicines Ltd. 458.68B 457.16B 1.15B -
3 Vertex Pharmaceuticals Inc / Ma 102.37B 99.35B - 700,000
4 Benitec Biopharma Inc. 65.38B 65.31B - 2.25M
5 Regeneron Pharmaceuticals, Inc. 60.67B 60.28B - -
6 Alnylam Pharmaceuticals, Inc. 60.53B 62.66B - -
7 Argenx Se 45.96B 50.00B - -
8 INSMED Inc 26.50B 27.40B - -
9 BioNTech SE 25.15B 17.24B - -
10 Nuvation Bio Inc. 1.42B 1.38B 2.26M 166,000

Historic Data

Download Data 🔒
Date Value
Jun 30, 2025 166,000
Jun 30, 2025 166,000
Mar 31, 2025 534,000
Mar 31, 2025 534,000
Dec 31, 2024 7.63M
Dec 31, 2024 7.63M
Sep 30, 2024 3.21M
Sep 30, 2024 3.21M
Jun 30, 2024 6.32M
Jun 30, 2024 6.32M
Dec 31, 2023 -3,000
Dec 31, 2023 -3,000